Network Organisations

The European FH Patient Network actively working to improve Europe-wide awareness, understanding, and access to diagnosis and treatment of inherited lipid conditions, (specifically FH, HoFH, Lp(a), FCS), so that all those impacted receive optimal treatment and support, resulting in longer and healthier lives

Countries

The European FH Patient Network actively working to improve Europe-wide awareness, understanding, and access to diagnosis and treatment of inherited lipid conditions, (specifically FH, HoFH, Lp(a), FCS), so that all those impacted receive optimal treatment and support, resulting in longer and healthier lives

Network Organisations

Countries

who we are

FH Europe consists of multiple FH patient groups across Europe. By sharing information & best practice we aim to secure early identification and diagnosis.

More info

about fh

Familial Hypercholesterolaemia (FH) is an inherited genetic condition that leads to levels of cholesterol that are much higher than that of the general population.

More info

Our NETWORK

The network is made up of organisations and individuals that represent FH patient groups within their specific European country.

More info

Latest News

Heart Beat News – December 2021

Heart Beat News – December 2021

In the December edition of FH Europe’s Heart Beat newsletter you’ll find the following: A special “End of Year” message from FH Europe’s Chair of the Board and Chief Executive. Information on how you can become a trustee of FH Europe, as we begin the search for new...

End of Year message

End of Year message

As the year draws to a close, we would like share with our community an End of Year message. Despite the uncertainties and the difficulties that 2021 has brought, FH Europe has had a very positive year. Although those have been very intense 12 months, the organization...

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt
Site by: Vovi Web Design